Conversely, LGR5− glioma cells showed low expression of CD133, CD44, CD90, CD24, and EpCAM, while the expression of CD90 remained unchanged in LGR5+ and LGR5− glioma cells (Fig. 3a). This evidence concerns the gene EPCAM and central nervous system cancer.